Israel Englander Xeris Biopharma Holdings, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,317,972 shares of XERS stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,317,972
Previous 1,948,552
18.96%
Holding current value
$11.9 Million
Previous $6.61 Million
92.66%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XERS
# of Institutions
205Shares Held
84.6MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$52.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$41.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$17.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$17 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $696M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...